Nova Steroid Pharma Co.,Ltd
IGF1-LR3 Powder For Bodybuilding CAS:143045-27-6

IGF1-LR3 Powder For Bodybuilding CAS:143045-27-6

IGF1-LR3 (Insulin-like Growth Factor 1 Long R3) is a synthetic, modified variant of natural IGF-1, engineered to enhance its stability and longevity in the human body. Unlike endogenous IGF-1, which has a fleeting presence due to rapid degradation, IGF1-LR3 incorporates a 13-amino acid extension at the N-terminus and an arginine-to-glutamine substitution at position 3.

Send Inquiry
Description

    Introduction to IGF1-LR3

    IGF1-LR3 (Insulin-like Growth Factor 1 Long R3) is a synthetic, modified variant of natural IGF-1, engineered to enhance its stability and longevity in the human body. Unlike endogenous IGF-1, which has a fleeting presence due to rapid degradation, IGF1-LR3 incorporates a 13-amino acid extension at the N-terminus and an arginine-to-glutamine substitution at position 3. This "Long R3" modification reduces binding to inhibitory proteins, prolonging its half-life and amplifying its anabolic effects. Initially developed for research into cellular growth and metabolic disorders, it has been co-opted by bodybuilders seeking accelerated muscle hypertrophy and recovery.

glp-1-bodybuilding-featured

master-bb

Structural and Functional Features

    1.Extended Half-Life: The LR3 modification shields the molecule from proteolytic enzymes and decreases affinity for IGF-binding proteins (IGFBPs), allowing it to remain active for 20–30 hours, compared to regular IGF-1's 10–12 minutes.

    2.Lyophilized Form: Sold as a freeze-dried powder, IGF1-LR3 requires reconstitution with acetic acid or bacteriostatic water to maintain stability. This form ensures longevity but demands careful handling to avoid denaturation.

    3.Receptor Interaction: Binds preferentially to the IGF-1 receptor (IGF-1R) over the insulin receptor, though cross-reactivity can influence glucose metabolism, necessitating caution in dosing timing.

Applications in Bodybuilding

    1.Muscle Hyperplasia and Hypertrophy: IGF1-LR3 stimulates satellite cell activation, promoting the fusion of myoblasts to damaged muscle fibers, thereby increasing muscle cell count (hyperplasia) and size (hypertrophy).

    2.Lipolytic Effects: Enhances fat oxidation by upregulating hormone-sensitive lipase, making it popular during cutting phases.

    3.Recovery Acceleration: Reduces inflammation and accelerates protein synthesis post-exercise, enabling more frequent, intense training sessions.

    4.Synergistic Use: Often stacked with growth hormone (HGH) or selective androgen receptor modulators (SARMs) to amplify muscle growth, leveraging HGH's role in endogenous IGF-1 production.

Unique Benefits Over Conventional IGF-1

    1.Prolonged Activity: The extended half-life allows once-daily injections, contrasting with multiple doses needed for unmodified IGF-1.

    2.Targeted Tissue Growth: Shows a predilection for skeletal muscle and connective tissue, potentially reducing off-target organ growth risks when used responsibly.

    3.Enhanced Bioavailability: Reduced binding to IGFBPs increases free IGF-1 levels, maximizing receptor activation.

Unique Benefits Over Conventional IGF-1

    1.Prolonged Activity: The extended half-life allows once-daily injections, contrasting with multiple doses needed for unmodified IGF-1.

    2.Targeted Tissue Growth: Shows a predilection for skeletal muscle and connective tissue, potentially reducing off-target organ growth risks when used responsibly.

    3.Enhanced Bioavailability: Reduced binding to IGFBPs increases free IGF-1 levels, maximizing receptor activation.

Dosage Protocols and Administration

    1.Microgram Dosing: Typical doses range 20–120 mcg/day, often split into pre- and post-workout injections to capitalize on nutrient uptake. Beginners start at 20–40 mcg to assess tolerance.

    2.Reconstitution Guidelines: Use acetic acid (0.6% pH-adjusted) for optimal solubility. Avoid shaking; gently swirl to prevent protein aggregation.

    3.Injection Sites: Subcutaneous (abdomen, thighs) or intramuscular (deltoids, glutes) administration. Rotate sites to prevent lipoatrophy.

Cycling Strategies

    1.Cycle Length: 4–6 weeks on, followed by 4–8 weeks off to mitigate receptor desensitization. Prolonged use may downregulate IGF-1R, diminishing efficacy.

    2.Stacking Considerations: Paired with HGH, doses of IGF1-LR3 are often halved (e.g., 50 mcg IGF1-LR3 + 4 IU HGH) to avoid synergistic hypoglycemia.

Pharmacokinetics: Half-Life and Timing

    IGF1-LR3's half-life of ~20–30 hours permits once-daily dosing. Peak activity occurs 2–4 hours post-injection, aligning administration with workout periods for maximal nutrient shuttling.

  Post-Treatment Considerations (PTC)

    Though IGF1-LR3 doesn't suppress the hypothalamic-pituitary-testicular axis (HPTA) like steroids, users combining it with androgens may require traditional Post Cycle Therapy (PCT) (e.g., SERMs like tamoxifen). Standalone IGF1-LR3 cycles generally don't necessitate PCT but benefit from metabolic support (e.g., berberine for glucose regulation).

Risks and Mitigation Strategies

    1.Hypoglycemia: Common due to insulin-like activity. Counteract with complex carbs post-injection; avoid concurrent insulin use unless under medical supervision.

    2.Organomegaly: Chronic high doses may enlarge organs. Limit cycles to 6 weeks and avoid exceeding 100 mcg/day.

    3.Acromegaly Symptoms: Prolonged use can trigger joint pain or coarse facial features. Discontinue use if symptoms arise.

 Legal and Ethical Considerations

    IGF1-LR3 is classified as a research chemical, illegal for human use in many countries. Athletes face bans from organizations like WADA. Sourcing risks include counterfeit products; third-party testing is advised.

Practical User Tips

    1.Reconstitution: Use insulin syringes for precision. Store reconstituted peptides at 2–8°C for up to 14 days.

    2.Dietary Synergy: High-protein, moderate-carb diets optimize muscle synthesis while managing hypoglycemia.

    3.Monitoring: Regular blood glucose checks and IGF-1 level tests (via ELISA) ensure safety and efficacy.

Emerging Research and Alternatives

    Recent studies explore IGF1-LR3's role in neuroprotection and collagen synthesis, hinting at joint health benefits. Alternatives like PEGylated IGF-1 offer longer half-lives but lack empirical user data. Mechano Growth Factor (MGF) is another peptide used post-workout for localized growth.

Debunking Myths

    Contrary to anecdotal claims, IGF1-LR3 isn't a "magic bullet." It requires rigorous training and caloric surplus for significant gains. Misconceptions about causing instant muscle growth overlook the need for cellular adaptation over weeks.

Clinical Data

Trade names

Long R3-IGF-1; IGF-1 Long R3

CAS

143045-27-6

Molar mass

9117.60

Formula

C400H625N111O115S9

Purity

Above 98%

Apprarance

White crystalline powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-19128233885

   

QQ20240306150406                product-368-486                 product-521-245

 

Conclusion

   IGF1-LR3 offers bodybuilders a potent tool for enhancing muscle growth and recovery, but its use demands meticulous dosing, cycling, and health monitoring. While benefits are compelling, the legal ambiguities and health risks necessitate informed, cautious application.

    This guide synthesizes cutting-edge research and user experiences, presenting a nuanced view of IGF1-LR3's role in modern bodybuilding, distinct from prior discussions through its emphasis on molecular mechanisms, practical protocols, and ethical considerations.

Hot Tags: igf1-lr3 powder for bodybuilding cas:143045-27-6, China igf1-lr3 powder for bodybuilding cas:143045-27-6 manufacturers, suppliers, factory

Inquiry
goTop

(0/10)

clearall